These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Blumenfeld A; Gennings C; Cady R Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151 [TBL] [Abstract][Full Text] [Related]
7. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Goldstein J; Hoffman HD; Armellino JJ; Battikha JP; Hamelsky SW; Couch J; Blumenthal H; Lipton RB Cephalalgia; 1999 Sep; 19(7):684-91. PubMed ID: 10524663 [TBL] [Abstract][Full Text] [Related]
8. 2022 Taiwan Guidelines for Acute Treatment of Migraine. Lau CI; Wang YF; Acta Neurol Taiwan; 2022 Jun; 31(2)():89-113. PubMed ID: 36153693 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Lipton RB; Stewart WF; Ryan RE; Saper J; Silberstein S; Sheftell F Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363 [TBL] [Abstract][Full Text] [Related]
10. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Wenzel RG; Sarvis CA; Krause ML Pharmacotherapy; 2003 Apr; 23(4):494-505. PubMed ID: 12680479 [TBL] [Abstract][Full Text] [Related]
13. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417 [TBL] [Abstract][Full Text] [Related]
14. [Treatment guidelines for acute migraine attacks]. Treatment Guideline Subcommittee of Taiwan Headache Society Acta Neurol Taiwan; 2007 Dec; 16(4):251-68. PubMed ID: 18220021 [TBL] [Abstract][Full Text] [Related]
15. Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care. Diamond M; Cady R Am J Med; 2005 Mar; 118 Suppl 1():18S-27S. PubMed ID: 15841884 [TBL] [Abstract][Full Text] [Related]
16. Acute migraine treatment with oral triptans and NSAIDs in a managed care population. Ng-Mak DS; Hu XH; Chen YT; Ma L Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177 [TBL] [Abstract][Full Text] [Related]
18. Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine. Ezzati A; Fanning KM; Reed ML; Lipton RB Headache; 2023 Mar; 63(3):342-352. PubMed ID: 36748728 [TBL] [Abstract][Full Text] [Related]
19. How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine. Pringsheim T; Davenport WJ; Marmura MJ; Schwedt TJ; Silberstein S Headache; 2016 Jul; 56(7):1194-200. PubMed ID: 27322907 [TBL] [Abstract][Full Text] [Related]
20. The impact of an over-the-counter migraine medication program on quality of life. Burk CT; Gilderman A; Salas J; Berenbeim D; Nichol MB Headache; 2003 Mar; 43(3):191-201. PubMed ID: 12603637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]